000 04487naa a22006257i 4500
001 UMUN-OA-20261005-MLS-025
003 local
005 20261005174903.0
006 m o d
007 cr||||||||||||
008 261005s2020 xx o u000 0 eng d
024 7 _a10.2807/1560-7917.es.2020.25.8.1900393
_2doi
035 _a(local)EuropePMC:PMC7055039
040 _alocal
_beng
_clocal
041 0 _aeng
100 0 _aMaría Velasco
_eauthor.
245 1 0 _aScreening for Trypanosoma cruzi infection in immigrants and refugees: Systematic review and recommendations from the Spanish Society of Infectious Diseases and Clinical Microbiology. /
_cMaría Velasco; Luis Andrés Gimeno-Feliú; Israel Molina [and others].
264 1 _a[Place of publication not identified] :
_bEuropean Centre for Disease Prevention and Control,
_c2020.
300 _a1 online resource (1 article).
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
500 _aPublication type: Review article.
500 _aLinked open-access copy: published version.
506 0 _aOpen access; no subscription required for the linked open-access version.
_fUnrestricted online access
_2star
520 3 _aBackgroundChagas disease has spread beyond its original borders on the American continent with migration. It can be transmitted from mother to child, through organ transplantation and transfusion of blood and blood products. It is necessary to determine when to screen for this infection.AimOur objective was to evaluate the appropriateness of screening for Trypanosoma cruzi infection in Latin American migrants and their descendants.MethodsWe reviewed the literature using rigorous criteria. The quality of evidence was ranked according to the GRADE classification. An evidence to decision framework was adopted to provide information on the most relevant aspects necessary to formulate recommendations.ResultsThe 33 studies evaluated revealed a prevalence of T. cruzi infection among Latin American migrants in Europe of 6.08% (95% confidence interval (CI): 3.24-9.69; 28 studies). Vertical transmission occurred in three of 100 live births (95% CI: 1-6; 13 studies). The prevalence of cardiovascular disease was 19% (95% CI: 13-27; nine studies), including only 1% severe cardiac events (95% CI: 0-2; 11 studies). The overall quality of evidence was low because of risk of bias in the studies and considerable heterogeneity of the evaluated populations. The recommendations took into account economic studies on the value of screening strategies and studies on acceptability of screening and knowledge of the disease in the affected population.ConclusionsWe identified five situations in which screening for T. cruzi infection is indicated. We recommend screening persons from endemic areas and children of mothers from these areas.
540 _aCreative Commons Attribution. See the linked licence for the applicable terms.
_uhttp://creativecommons.org/licenses/by/4.0/
546 _aIn English.
588 0 _aDescription generated from Europe PMC bibliographic metadata retrieved on 5 October 2026; full text linked from the source.
590 _aCourse allocation: B. Sc. Medical Laboratory Science.
650 4 _aPregnancy
650 4 _aScreening
650 4 _aGrade
650 4 _aSystematic review
650 4 _aTrypanosoma Cruzi
650 4 _aChagas Disease
653 _aB. Sc. Medical Laboratory Science
653 _aUMUN open access collection
653 _aclinical microbiology
655 4 _aReview articles.
700 0 _aLuis Andrés Gimeno-Feliú
_eauthor.
700 0 _aIsrael Molina
_eauthor.
700 0 _aJoaquín Salas-Coronas
_eauthor.
700 0 _aIvan Solà
_eauthor.
700 0 _aBegoña Monge-Maillo
_eauthor.
700 0 _aDiego Torrús-Tendero
_eauthor.
700 0 _aJoan Caylà
_eauthor.
700 0 _aEna Niño de Guzmán
_eauthor.
700 0 _aJl Pérez Arellano
_eauthor.
700 0 _aJose A Pérez-Molina
_eauthor.
773 0 _tEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
_gVol. 25, no. 8, (2020)
_x1025-496X
856 4 0 _uhttps://europepmc.org/articles/PMC7055039
_yRead open-access publication
_zOpen access.
_70
884 _aCourse selection and automated MARC21 enrichment from Europe PMC metadata.
_g20261005
_khttps://europepmc.org/articles/PMC7055039
_qlocal
942 _n0
999 _c1167
_d1167